logo

For the Inventor, By the Inventor

Lincoln, NE, United States of America

James R Kulawik, Ii

This inventor holds 12 USPTO granted patents. Top assignee: Zoetis Services LLC. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James R Kulawik, Ii. Retrieved from https://idiyas.com/inventor/james-r-kulawik-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 62(Granted Patents)


Company Filing History:

goldMedal12 out of 225 
 
Zoetis Services LLC
 patents

Years Active: 2015-2021

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11154609 - PCV/mycoplasma hyopneumoniae vaccine (2021-10-26),
2. 11141472 - Mycoplasma hyopneumoniae vaccine (2021-10-12),
3. 10668145 - PCV/vaccine for use with PRRSV vaccine (2020-06-02),
4. 10668139 - vaccine (2020-06-02),
5. 10206993 - PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine (2019-02-19),
6. 10206991 - Mycoplasma hyopneumoniae vaccine (2019-02-19),
7. 9650601 - PCV/mycoplasma hyopneumoniae/PRRS combination vaccine (2017-05-16),
8. 9650600 - [object Object] (2017-05-16),
9. 9649369 - [object Object] (2017-05-16),
10. 9125886 - PCV/mycoplasma hyopneumoniae/PRRS combination vaccine (2015-09-08),
11. 9125885 - [object Object] (2015-09-08),
12. 9120859 - [object Object] (2015-09-01),

Title: The Innovative Work of James R Kulawik II in Veterinary Medicine

Introduction:

James R Kulawik II, a prolific inventor based in Lincoln, NE, has made significant contributions to the field of veterinary medicine with a total of 12 patents under his name. His groundbreaking inventions have revolutionized the way we approach porcine health and disease prevention.

Latest Patents:

Among his latest patents is the PCV/mycoplasma hyopneumoniae vaccine. This innovative vaccine provides a combination that includes a porcine circovirus type 2 (PCV2) antigen and a cell-free M. hyo culture supernatant. This combination effectively protects pigs against PCV2 and M. hyo infections, ensuring the M. hyo culture supernatant is free of PCV2 antibodies. Another significant invention is the Mycoplasma hyopneumoniae vaccine, which offers an M. hyo antigen compatible with antigens from other swine pathogens. The M. hyo antigen is a cell-free M. hyo culture supernatant that is substantially free of swine IgG.

Career Highlights:

Currently employed at Zoetis Services LLC, James R Kulawik II has demonstrated his expertise and passion for developing innovative solutions in veterinary medicine. With a keen focus on addressing crucial issues in porcine health, he continues to push boundaries and improve animal welfare through his inventive creations.

Collaborations:

Throughout his career, James R Kulawik II has collaborated with esteemed professionals in the field, including Gregory Paul Nitzel and Jeffrey E Galvin. These collaborations have not only enriched his work but have also led to the development of cutting-edge solutions that are transforming the landscape of veterinary medicine.

Conclusion:

In conclusion, James R Kulawik II stands as a visionary inventor whose dedication to advancing veterinary medicine has resulted in groundbreaking inventions that benefit the health and well-being of pigs. His innovative spirit, combined with his collaborative efforts, reinforces his position as a leading figure in the field, shaping the future of animal healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…